These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22208048)

  • 1. [Palliative pain relief treatment for multiple bone metastases by strontium-89].
    Nishio M
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():581-5. PubMed ID: 22208048
    [No Abstract]   [Full Text] [Related]  

  • 2. [89-Strontium for painful osteoblastic metastases].
    Golan H; Ratz D
    Harefuah; 1995 May; 128(10):650-4. PubMed ID: 7541384
    [No Abstract]   [Full Text] [Related]  

  • 3. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.
    Bolger JJ; Dearnaley DP; Kirk D; Lewington VJ; Mason MD; Quilty PM; Reed NS; Russell JM; Yardley J
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):32-3. PubMed ID: 7684863
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating symptomatic osseous metastases from prostate cancer.
    Soffen EM; Greenberg AS; Baumann JC
    N J Med; 1997 Nov; 94(11):33-7. PubMed ID: 9385818
    [No Abstract]   [Full Text] [Related]  

  • 5. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.
    Hansen DV; Holmes ER; Catton G; Thorne DA; Chadwick DH; Schmutz DA
    Am Fam Physician; 1993 Jun; 47(8):1795-800. PubMed ID: 7684554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer].
    Haesner M; Buchali K; Pink V; Lips H
    Nuklearmedizin; 1992 Mar; 31(2):48-52. PubMed ID: 1373485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
    Flamm J; Burkert S
    Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strontium-89 for bone metastases from prostate cancer: an update].
    Zhao WW; Xie P; Deng HF
    Zhonghua Nan Ke Xue; 2010 Mar; 16(3):269-72. PubMed ID: 20369560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated intravascular coagulation in metastatic prostate cancer.
    Riddell AJ
    J Nucl Med; 1996 Feb; 37(2):401. PubMed ID: 8667086
    [No Abstract]   [Full Text] [Related]  

  • 10. Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial.
    Porter AT; McEwan AJ
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):38-43. PubMed ID: 7684865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium 89 in the treatment of bony metastases.
    Porter AT; Ben-Josef E
    Important Adv Oncol; 1995; ():87-94. PubMed ID: 7545646
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma.
    Breen SL; Powe JE; Porter AT
    J Nucl Med; 1992 Jul; 33(7):1316-23. PubMed ID: 1613572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioactive strontium-89 for painful bone metastases.
    Med Lett Drugs Ther; 1993 Oct; 35(908):102. PubMed ID: 7692227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
    Ouyang W; Liu JH; Liu WY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic radionuclide therapy of bone metastases with strontium-89.
    Porter AT; Davis LP
    Oncology (Williston Park); 1994 Feb; 8(2):93-6; discussion 96, 99-101. PubMed ID: 8167090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Question of the month--January 1995. What is the optimal dose of 89Sr for bone pain palliation?
    Khader Z
    Nucl Med Commun; 1995 Apr; 16(4):306. PubMed ID: 7542759
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of osseous metastases of hormone-refractory prostate cancer with external beam radiotherapy and Strontium-89.
    De Ruysscher D; Spaas P; Specenier P
    Acta Urol Belg; 1996 Sep; 64(3):13-9. PubMed ID: 8946776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of painful osteoblastic metastases: what can we expect from nuclear oncology?
    Silberstein EB
    J Nucl Med; 1994 Dec; 35(12):1994-5. PubMed ID: 7527457
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
    Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
    Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.